5 Neurology And CNS Disorders companies

Invested in breaking ‍through paralysis.

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

We build and invest in companies that transform healthcare.

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation.

A CHF 50M venture capital fund aimed at supporting the development of neuroenhancement technologies.